Cipla (BOM:500087) Cyclically Adjusted Revenue per Share: ₹313.55 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500087 Cipla Ltd BOM:500087
96 GF Score
Price ₹1,473.00
GF Value ₹1,555.98
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cipla Cyclically Adjusted Revenue per Share?

Cipla BOM:500087 +0.48% 96 Cyclically Adjusted Revenue per Share is ₹313.55 as of Jun. 2026. GuruFocus rates BOM:500087 with a GF Score™ of 96/100 and a GF Value™ of ₹1,555.98 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cipla's adjusted revenue per share for the three months ended in Jun. 2026 was ₹87.538. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹313.55 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Cipla's average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cipla was 8.80% per year. The lowest was 7.40% per year. And the median was 8.50% per year.

As of today (2026-08-01), Cipla's current stock price is ₹1473.00. Cipla's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹313.55. Cipla's Cyclically Adjusted PS Ratio of today is 4.70.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cipla was 6.03. The lowest was 2.00. And the median was 4.47.


Cipla  (BOM:500087) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cipla's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1473.00/313.55
=4.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cipla was 6.03. The lowest was 2.00. And the median was 4.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cipla Cyclically Adjusted Revenue per Share Related Terms


Cipla Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cipla's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Cyclically Adjusted Revenue per Share Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 225.78 248.78 269.58 288.27 308.21

Cipla Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.30 300.48 304.87 308.21 313.55

BOM:500087 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipla Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cipla's Cyclically Adjusted PS Ratio falls into.


BOM:500087
96GF Score
Cipla Ltd BOM:500087
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipla Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipla's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=87.538/166.1454*166.1454
=87.538

Current CPI (Jun. 2026) = 166.1454.

Cipla Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 45.595 105.961 71.492
201612 44.210 105.196 69.825
201703 43.454 105.196 68.631
201706 42.566 107.109 66.028
201709 49.453 109.021 75.365
201712 47.583 109.404 72.262
201803 43.451 109.786 65.757
201806 47.642 111.317 71.108
201809 48.898 115.142 70.558
201812 48.445 115.142 69.904
201903 52.974 118.202 74.460
201906 48.295 120.880 66.380
201909 52.834 123.175 71.265
201912 52.475 126.235 69.065
202003 53.245 124.705 70.939
202006 52.988 127.000 69.320
202009 61.575 130.118 78.624
202012 63.794 130.889 80.978
202103 56.783 131.771 71.596
202106 67.741 134.084 83.939
202109 67.863 135.847 82.999
202112 67.382 138.161 81.030
202203 64.736 138.822 77.478
202206 65.854 142.347 76.864
202209 71.325 144.661 81.918
202212 70.968 145.763 80.892
202303 70.181 146.865 79.395
202306 77.635 150.280 85.831
202309 81.571 151.492 89.461
202312 80.527 152.924 87.489
202403 75.263 153.035 81.711
202406 81.964 155.789 87.413
202409 86.151 157.882 90.660
202412 86.127 158.323 90.382
202503 81.645 157.552 86.098
202506 84.619 159.755 88.004
202509 92.158 162.289 94.348
202512 86.136 163.281 87.647
202603 79.952 164.272 80.864
202606 87.538 166.145 87.538

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹313.55 mean?
Cipla (BOM:500087) has a Cyclically Adjusted Revenue per Share of ₹313.55 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cipla and its competitors.
Is Cipla's Cyclically Adjusted Revenue per Share too high?
Cipla's current Cyclically Adjusted Revenue per Share is ₹313.55. Overall, Cipla has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipla's Cyclically Adjusted Revenue per Share compare to ZTS?
Cipla's Cyclically Adjusted Revenue per Share of ₹313.55 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cipla and its competitors. Cipla's current Cyclically Adjusted Revenue per Share is ₹313.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Based on GuruFocus' analysis, Cipla (BOM:500087) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,555.98, compared to a current price of ₹1,473.00 — trading 5.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹313.55. Cipla's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cipla (BOM:500087), the current Cyclically Adjusted Revenue per Share is ₹313.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipla (BOM:500087) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of ₹1,473.00 is trading 5.3% below its estimated GF Value™ of ₹1,555.98. GuruFocus considers Cipla to be Fairly Valued.

Key valuation signals for BOM:500087:

  • Cyclically Adjusted Revenue per Share: ₹313.55
  • GF Value™: ₹1,555.98 vs. price of ₹1,473.00 (5.3% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the BOM:500087 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cipla Business Description

Other Exchanges CIPLA:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
96GF Score

Get the complete analysis for BOM:500087

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,473.00
Price
₹1,555.98
GF Value